HLS Therapeutics (HLS.TO) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.16
-0.12
-0.09

Details

Expected EPS
-0.087434312
Actual EPS
-0.1684128
Surprise EPS
-0.08
Surprise Percent
+92.62%

Description

HLS Therapeutics (HLS.TO) has reported earnings of -0.1684128 per share for Q4 2025.

0 Comments

Share your thoughts